Skip to main content

Table 2 Number of statins on KNHI benefit list (2005–2009 year)*

From: Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea

Year

2005

2006

2007

2008

2009

Statins

Original

Generic**

Original

Generic**

Original

Generic**

Original

Generic**

Original

Generic**

Simvastatin (10, 20, 40, 80 mg)

3

125

3

134

3

135

3

118

4

100

Lovastatin (20 mg)

1

54

1

56

1

52

1

35

1

25

Pravastatin (5,10,20,40 mg)

0

49

0

50

0

81

0

56

0

48

Fluvastatin (20,40,80 mg)

3

0

3

0

3

0

3

0

3

0

Atorvastatin (10,20,40,80 mg)

3

0

3

0

3

0

4

42

4

54

Rosuvastatin (5,10,20 mg)

2

0

3

0

3

0

3

0

3

0

Pitavastatin (2 mg)

1

0

1

0

1

0

1

0

1

0

Total

241

254

282

266

243

  1. *They include all statins on the KNHI benefit list between 2005 and 2009, regardless of whether they were actually prescribed or not.
  2. **The original and generic drugs were categorized only according to their ingredients and contents. Different administration routes, dosage forms, and strength of unit were not taken into account.